Green Thumb Industries (GTBIF) Non Operating Income (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Non Operating Income came in at $22.4 million in Q1 2026, up 910.01% YoY from $2.2 million in Q1 2025, and down 79.51% on a QoQ basis from $109.4 million in Q4 2025.
Green Thumb Industries (GTBIF) Non Operating Income (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Non Operating Income data on file, last reported at $22.4 million in Q1 2026.
- Quarterly Non Operating Income rose 910.01% year-over-year to $22.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $150.8 million (up 858.76% YoY) and the FY2025 annual result came in at $125.7 million, up 617.4% from the prior year.
- Non Operating Income declined to $22.4 million in Q1 2026, from $109.4 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $109.4 million in Q4 2025 to a low of -$22.1 million in Q4 2023.
- A 5-year average of $4.9 million and a median of -$2.8 million in 2025 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 1338.69% in 2025, down 1323.52% in 2025.
- Tracing GTBIF's Non Operating Income over 5 years: stood at -$14.1 million in 2022, then tumbled by 57.31% to -$22.1 million in 2023, then soared by 41.28% to -$13.0 million in 2024, then soared by 942.04% to $109.4 million in 2025, then slumped by 79.51% to $22.4 million in 2026.
- The last three Non Operating Income figures came in at $22.4 million (Q1 2026), $109.4 million (Q4 2025), and $36.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | -4.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.02 Mn |
| Mar 31, 2026 | 22.41 Mn |
| Dec 31, 2025 | 109.36 Mn |
| Sep 30, 2025 | 36.18 Mn |
| Jun 30, 2025 | -17.13 Mn |
| Mar 31, 2025 | -2.77 Mn |
| Dec 31, 2024 | -12.99 Mn |
| Sep 30, 2024 | -2.92 Mn |
| Jun 30, 2024 | -1.20 Mn |
| Mar 31, 2024 | -7.17 Mn |
| Dec 31, 2023 | -22.12 Mn |
| Sep 30, 2023 | -3.69 Mn |
| Jun 30, 2023 | -1.61 Mn |
| Mar 31, 2023 | -1.16 Mn |
| Dec 31, 2022 | -14.06 Mn |
| Sep 30, 2022 | -5.64 Mn |
| Jun 30, 2022 | 808,000.00 |
| Mar 31, 2022 | 6.27 Mn |
| Dec 31, 2021 | -3.93 Mn |
| Sep 30, 2021 | 837,000.00 |